Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).

Clinical trial NCT06399341 · COMPLETED

Trial details

NCT number: NCT06399341
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Papillomavirus Infections

Start date: 2021-09-01
Primary completion: 2023-04-30
Enrollment: 524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.